SWOG clinical trial number
CTSU/N0147
A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer
Closed
Phase
Published
Abbreviated Title
Colon Ph III oxaliplatin, 5-FU, leucovorin +/- cetuximab
Activated
08/01/2004
Closed
11/25/2009
Participants
CTSU
Research committees
Gastrointestinal Cancer
Treatment
5-Fluorouracil
Irinotecan
Leucovorin Calcium
Oxaliplatin
Cetuximab
Atropine Sulfate
Loperamide
Eligibility Criteria Expand/Collapse
Publication Information Expand/Collapse
Other Clinical Trials
S2303
SWOG Clinical Trial Number
Research Committee(s)
Gastrointestinal Cancer
Activated
05/06/2024
Open
CTSU/A022101
SWOG Clinical Trial Number
Research Committee(s)
Gastrointestinal Cancer
Activated
01/10/2023
Open
Phase
S2107
SWOG Clinical Trial Number
Research Committee(s)
Gastrointestinal Cancer
Activated
06/06/2022
100% Accrual
Accrual
100%
Open
Phase